Startups

YC-backed Perlstein Lab continues their rare disease drug discovery

Comment

Image Credits:

Perlstein Lab, or PLab as it is also known, continues to hone its automated drug discovery platform and presents its latest iteration Wednesday March 23rd at Y Combinator Demo Day. The platform they created helps the bio startup focus on finding cures for rare diseases rather than common ones. This novel approach is different from most Big Pharma labs and is thus one of their differentiators.

What is an “automated drug discovery platform?” I asked this to PLab founder and CEO Ethan Perlstein and he summarized for me. Hold onto your braincells, we’re about to get a little technical.

First of all, it is important to know that, according to Perlstein, there are about 7000 diseases classified as rare and 95% of these have no FDA approved cure. This is PLab’s area of focus. This is a much different model than Big Pharma which usually focuses on more common illnesses where the research ROI stands to be much greater.

Of these 7000 rare diseases, about half are caused by a single broken gene. These are usually inherited diseases and affect children.

PLab focuses on single broken gene diseases initially because they are obviously less complex and easier to approach. Using a molecular apparatus known as a CRISPR—which Perlstein likened to a command line editor for animal genomes—PLab alters the genome of test animals (yeasts, flies, worms, fish and sometimes mice) to mimic the broken gene disorder…to essentially, make them ill. Because many of these animal are small, even microscopic, PLab can have large numbers of them to test against.

Then, using an automated platform, they apply thousands of chemical compounds to these animals to see which compounds are effective at reversing or bypassing the loss of the broken gene’s function.

In this way they can rapidly and effectively test for cures.

Using these complex animal types is key to effectiveness according to Perlstein, and differentiates their lab in many ways from Big Pharma, who often focus on cellular tests in petri dishes rather than live organisms.

I did have to ask Perlstein what he thought the general public might think about their animal testing. He responded by saying that they prioritize by the least complex animals first—yeasts, worms, flies and fish—an only move up to mice if necessary. However, he indicated that even when testing on mice becomes necessary, they are not doing anything differently from many Pharma companies out there that also test on mice.

The second future phase they have planned is to add a predictive learning model to this automated platform that will become faster over time and generate many more insights more quickly and efficiently.

So that’s an extremely simplified version of how their technology works. How they plan to enter the market revolves around two main business models which could be summarized as Lead Gen and Accelerator.

In one model, they plan to operate as sort of a scout or lead generation partner to larger pharmaceutical companies. For example, when the ROI makes it much harder for a big pharma company to dive into research on a rare disease, PLab could use their intellectual property to be the research partner and to efficiently determine a reasonable disease to target. Then they hand off the results to the larger company to conduct clinical trials. They are currently discussing partnerships now.

To bolster this, PLab has calculated a market size of $1 million per person afflicted.

A second, more radical model, involves ultra-rare diseases. These are diseases that afflict less than one person in a million. These are diseases that larger pharmaceutical companies definitely don’t focus on.  However, many of the families of the afflicted are already raising funds on their own to contribute to research. In this business model, PLab will work directly with these patient families. Each disease would spin off as a separate research-based startup company focused on that disease. PLab would take a cut of the business they help accelerate.

PLab was already quite busy before joining Y Combinator and had already raised a total of $2.5 million from several investors including Retrophin and their infamous ex-CEO Martin Shkreli. However they have severed all ties with Skreli and are not linked with him any longer. PLab has also raised another $1 million convertible note via Slow Ventures.

UPDATE: Slow Ventures only invested $500,000 on the $1 million convertible note. The other $500,000 on the note is a mix of angels and existing investors.

More TechCrunch

Copilot, Microsoft’s brand of generative AI, will soon be far more deeply integrated into the Windows 11 experience.

Microsoft Build 2024: All the AI and hardware products Microsoft announced

Hello and welcome back to TechCrunch Space. For those who haven’t heard, the first crewed launch of Boeing’s Starliner capsule has been pushed back yet again to no earlier than…

TechCrunch Space: Star(side)liner

When I attended Automate in Chicago a few weeks back, multiple people thanked me for TechCrunch’s semi-regular robotics job report. It’s always edifying to get that feedback in person. While…

These 81 robotics companies are hiring

The top vehicle safety regulator in the U.S. has launched a formal probe into an April crash involving the all-electric VinFast VF8 SUV that claimed the lives of a family…

VinFast crash that killed family of four now under federal investigation

When putting a video portal in a public park in the middle of New York City, some inappropriate behavior will likely occur. The Portal, the vision of Lithuanian artist and…

NYC-Dublin real-time video portal reopens with some fixes to prevent inappropriate behavior

Longtime New York-based seed investor, Contour Venture Partners, is making progress on its latest flagship fund after lowering its target. The firm closed on $42 million, raised from 64 backers,…

Contour Venture Partners, an early investor in Datadog and Movable Ink, lowers the target for its fifth fund

Meta’s Oversight Board has now extended its scope to include the company’s newest platform, Instagram Threads, and has begun hearing cases from Threads.

Meta’s Oversight Board takes its first Threads case

The company says it’s refocusing and prioritizing fewer initiatives that will have the biggest impact on customers and add value to the business.

SeekOut, a recruiting startup last valued at $1.2 billion, lays off 30% of its workforce

The U.K.’s self-proclaimed “world-leading” regulations for self-driving cars are now official, after the Automated Vehicles (AV) Act received royal assent — the final rubber stamp any legislation must go through…

UK’s autonomous vehicle legislation becomes law, paving the way for first driverless cars by 2026

ChatGPT, OpenAI’s text-generating AI chatbot, has taken the world by storm. What started as a tool to hyper-charge productivity through writing essays and code with short text prompts has evolved…

ChatGPT: Everything you need to know about the AI-powered chatbot

SoLo Funds CEO Travis Holoway: “Regulators seem driven by press releases when they should be motivated by true consumer protection and empowering equitable solutions.”

Fintech lender SoLo Funds is being sued again by the government over its lending practices

Hard tech startups generate a lot of buzz, but there’s a growing cohort of companies building digital tools squarely focused on making hard tech development faster, more efficient and —…

Rollup wants to be the hardware engineer’s workhorse

TechCrunch Disrupt 2024 is not just about groundbreaking innovations, insightful panels, and visionary speakers — it’s also about listening to YOU, the audience, and what you feel is top of…

Disrupt Audience Choice vote closes Friday

Google says the new SDK would help Google expand on its core mission of connecting the right audience to the right content at the right time.

Google is launching a new Android feature to drive users back into their installed apps

Jolla has taken the official wraps off the first version of its personal server-based AI assistant in the making. The reborn startup is building a privacy-focused AI device — aka…

Jolla debuts privacy-focused AI hardware

OpenAI is removing one of the voices used by ChatGPT after users found that it sounded similar to Scarlett Johansson, the company announced on Monday. The voice, called Sky, is…

OpenAI to remove ChatGPT’s Scarlett Johansson-like voice

The ChatGPT mobile app’s net revenue first jumped 22% on the day of the GPT-4o launch and continued to grow in the following days.

ChatGPT’s mobile app revenue saw its biggest spike yet following GPT-4o launch

Dating app maker Bumble has acquired Geneva, an online platform built around forming real-world groups and clubs. The company said that the deal is designed to help it expand its…

Bumble buys community building app Geneva to expand further into friendships

CyberArk — one of the army of larger security companies founded out of Israel — is acquiring Venafi, a specialist in machine identity, for $1.54 billion. 

CyberArk snaps up Venafi for $1.54B to ramp up in machine-to-machine security

Founder-market fit is one of the most crucial factors in a startup’s success, and operators (someone involved in the day-to-day operations of a startup) turned founders have an almost unfair advantage…

OpenseedVC, which backs operators in Africa and Europe starting their companies, reaches first close of $10M fund

A Singapore High Court has effectively approved Pine Labs’ request to shift its operations to India.

Pine Labs gets Singapore court approval to shift base to India

The AI Safety Institute, a U.K. body that aims to assess and address risks in AI platforms, has said it will open a second location in San Francisco. 

UK opens office in San Francisco to tackle AI risk

Companies are always looking for an edge, and searching for ways to encourage their employees to innovate. One way to do that is by running an internal hackathon around a…

Why companies are turning to internal hackathons

Featured Article

I’m rooting for Melinda French Gates to fix tech’s broken ‘brilliant jerk’ culture

Women in tech still face a shocking level of mistreatment at work. Melinda French Gates is one of the few working to change that.

1 day ago
I’m rooting for Melinda French Gates to fix tech’s  broken ‘brilliant jerk’ culture

Blue Origin has successfully completed its NS-25 mission, resuming crewed flights for the first time in nearly two years. The mission brought six tourist crew members to the edge of…

Blue Origin successfully launches its first crewed mission since 2022

Creative Artists Agency (CAA), one of the top entertainment and sports talent agencies, is hoping to be at the forefront of AI protection services for celebrities in Hollywood. With many…

Hollywood agency CAA aims to help stars manage their own AI likenesses

Expedia says Rathi Murthy and Sreenivas Rachamadugu, respectively its CTO and senior vice president of core services product & engineering, are no longer employed at the travel booking company. In…

Expedia says two execs dismissed after ‘violation of company policy’

Welcome back to TechCrunch’s Week in Review. This week had two major events from OpenAI and Google. OpenAI’s spring update event saw the reveal of its new model, GPT-4o, which…

OpenAI and Google lay out their competing AI visions

When Jeffrey Wang posted to X asking if anyone wanted to go in on an order of fancy-but-affordable office nap pods, he didn’t expect the post to go viral.

With AI startups booming, nap pods and Silicon Valley hustle culture are back

OpenAI’s Superalignment team, responsible for developing ways to govern and steer “superintelligent” AI systems, was promised 20% of the company’s compute resources, according to a person from that team. But…

OpenAI created a team to control ‘superintelligent’ AI — then let it wither, source says